Skip to main content

Metabolic surgery

17-09-2021 | Metabolic surgery | News

Better cardiovascular outcomes with gastric bypass vs sleeve gastrectomy

Among people with type 2 diabetes and obesity who undergo metabolic surgery, Roux-en-Y gastric bypass is associated with a lower risk for major adverse cardiovascular events than sleeve gastrectomy, suggests a secondary analysis of a cohort study.

09-07-2021 | Obesity | News

Brain MRI offers clues to weight regain after surgery vs diet

Divergent changes in brain activity after bariatric surgery versus a very-low-calorie diet may help explain why people are more likely to regain weight after the latter intervention, a study suggests.

19-05-2021 | Semaglutide | News

Semaglutide boosts weight loss of minimally invasive gastric procedure

Giving semaglutide to people undergoing minimally invasive endoscopic sleeve gastroplasty may bring weight loss closer to that induced by bariatric surgery, shows research.

25-01-2021 | Metabolic surgery | News

Glycemic benefits of metabolic surgery endure for at least 10 years

Metabolic surgery can result in type 2 diabetes remission lasting for at least 10 years, and people who relapse still achieve markedly improved glycemic control, shows follow-up from a randomized trial published in The Lancet.

14-12-2020 | Metabolic surgery | News

Support for bariatric surgery in people with insulin-dependent type 2 diabetes

Treatment with bariatric surgery is associated with clinical and cost-saving benefits among obese people with type 2 diabetes requiring insulin, researchers report.

13-10-2020 | Metabolic surgery | News

Bariatric surgery cuts pancreatic cancer risk in obese individuals with diabetes

Bariatric surgery is associated with a reduced prevalence of pancreatic cancer in obese individuals with type 2 diabetes, suggest findings from a population-based study presented at UEG Week Virtual 2020.

24-03-2020 | Metabolic surgery | News

Gastric bypass benefits are wide-ranging and universally applicable in type 2 diabetes

Weight loss after gastric bypass surgery results in important cardiovascular and renal benefits for obese people with type 2 diabetes, irrespective of their baseline renal function, observational cohort study data show.

31-10-2019 | Metabolic surgery | Highlight | News

Trial results support gastric bypass as ‘procedure of choice’ for diabetes remission

People with obesity and type 2 diabetes who undergo gastric bypass surgery have higher rates of diabetes remission after 1 year than those undergoing sleeve gastrectomy, indicate findings from the Oseberg trial.

Image Credits